Sign in
4

Changes in Ownership

Traws Pharma, Inc. Filed Acc 0001179110-21-002007

Options or other derivatives

  • Chief Financial Officer acquired 301,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Guerin Mark Patrick Chief Financial Officer 2021-02-17 Grant or award · Stock Appreciation Right +301,000 301,000 D
Loading xslF345X03/edgar.xml…